Vanda Pharmaceuticals, Inc. (VNDA)
7.56
+0.05
(+0.67%)
USD |
NASDAQ |
Feb 10, 10:06
Vanda Pharmaceuticals Shareholders Equity (Quarterly) : 466.00M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Eli Lilly & Co. | -- |
| AbbVie, Inc. | -- |
| Axsome Therapeutics, Inc. | 73.73M |
| AnaptysBio, Inc. | -29.42M |
| SELLAS Life Sciences Group, Inc. | 45.63M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 601.14M |
| Total Liabilities (Quarterly) | 135.14M |
| Debt to Equity Ratio | 0.0234 |
| Current Ratio | 3.118 |
| Net Debt Paydown Yield | -0.17% |